Codelivery of Doxorubicin/PI3K Inhibitor Nanomicelle Linked with Phenylboronic Acid for Enhanced Cytotoxicity to Pancreatic Cancer

Figure 3

Characterization of PPD and PF@PPD nanomicelles. Size of PPD NPs (a) and PF@PPD NPs (b). Zeta potential of PPD NPs (c) and PF@PPD NPs (d) measured by DLS. TEM of PPD NPs (e) and PF@PPD NPs (f).

(a)

(b)

(c)

(d)

(e)

(f)